Guidance and policy markers identify dated publications in the curated catalogue; they do not by themselves establish that an official policy changed on that date.
Why it matters nowThe endemic pattern and age distribution shift suggest brucellosis remains a persistent occupational health concern in pastoral regions. The authors recommend prevention efforts targeting endemic hotspots, periods of livestock exposure (particularly birthing season), and sustained surveillance during public health emergencies.
Why it matters nowThe authors suggest that ongoing airport wastewater monitoring may offer early alerts to health agencies and support coordinated response, pending cross-border cooperation.
Why it matters nowPregnancy-related COVID-19 outcomes are relevant to maternal and infant health surveillance, particularly assessment of severity-stratified risks for pregnancy complications and the potential for changing clinical management recommendations to alter outcome trends.
Peer reviewed Open accessVenezuelan equine encephalitisSARSTreatment
Why it matters nowVEEV is an emergent arbovirus associated with periodic outbreaks in Central and South America, causing high morbidity due to a 1:1 clinical-to-subclinical ratio and neurological disease in up to 14% of cases. No FDA-approved vaccines or therapeutics for VEEV currently exist.
Why it matters nowThe findings indicate that SARS-CoV-2 infection during pregnancy poses particular risks for adverse birth outcomes among women living with HIV in high-burden settings, suggesting need for integrated antenatal care and targeted infection prevention strategies in this population.
Why it matters nowThe authors describe considerable vaccination gaps in sepsis survivors and identify general-practitioner counselling and vaccination-status checks as potential elements of sepsis aftercare.
Why it matters nowThe authors suggest that cryobiopsy histopathology combined with virological findings and clinical course may add complementary information for treatment selection in this type of patient. This is a single-case observation and does not address population-level health outcomes.
Why it matters nowFindings indicate booster mRNA vaccination may reduce severe outcomes in a high-risk dialysis group, supporting booster use in this population.
Why it matters nowThe study supplies baseline data on coronavirus RNA in an understudied specimen and suggests stool-based screening could complement future One Health surveillance, though RNA presence alone is not infectivity.
Why it matters nowThe results suggest the dimer interface and allosteric sites may be useful to guide future main protease inhibitor design against SARS-CoV-2.
Why it matters nowEnhanced integrated surveillance during a mass sporting event provided insight into how layered risk measures corresponded with limited transmission among athletes.
Why it matters nowFindings inform how vaccine timing and regimen in pregnancy relate to antibody presence in mothers and infants, relevant to antenatal immunization planning in Thailand.
Why it matters nowPersistent zoonotic spillover and healthcare transmission with high mortality underscore the need for One Health surveillance, rapid detection, and infection control.
Why it matters nowPersistent serotype 3 circulation and non-vaccine serotype emergence indicate a continued need for surveillance and revised vaccine approaches.
Why it matters nowThe work shows that unsupervised methods can describe immune heterogeneity in frail older adults, helping distinguish observed antibody kinetics from direct protection estimates.
Why it matters nowThe capacity of these wildlife-associated viruses to infect human cellular models highlights the ongoing risk of zoonotic spillover events. The demonstrated cross-protection from current medical countermeasures suggests that existing pandemic preparedness strategies could help mitigate the impact of such emerging threats.
Why it matters nowThe work underscores the value of cardiovascular and renal monitoring in routine HIV care, given hypertension's tie to COVID-19 and proteinuria as a key CKD marker in this population.
Why it matters nowThe findings indicate a need for vaccination to boost weaker IgG responses and suggest vaccines should be adapted to viral evolution with improved mucosal delivery to enhance IgA responses.
Why it matters nowThe bireporter platform may support screening of antivirals and neutralizing antibodies against circulating SARS-CoV-2 variants of concern, which is relevant given reported immune escape and antiviral resistance among recent VoCs.
Why it matters nowThe authors suggest that characterizing AME versus non-AME antibody features could inform antigen design intended to avoid eliciting AME-eliciting antibodies and to promote antibodies that inhibit AME, with potential applications for COVID-19 vaccines and therapeutics.
Why it matters nowThe findings provide evidence on booster dose effectiveness and duration of protection against severe COVID-19 outcomes during a period when third doses were being widely deployed. The SCCS method may offer a useful approach for vaccine effectiveness analysis that automatically controls for time-invariant confounders.
Why it matters nowThe findings document SARS-CoV-2 detection in communities near a mountain-gorilla conservation area and provide context for assessing potential human-to-animal spillover risk. The abstract does not report confirmed spillover or transmission between humans and gorillas.
Why it matters nowThe paper provides policy-specific modeled evidence intended to inform pandemic preparedness. It addresses the potential importance of vaccination timing, testing and contact-tracing capacity, and adjustment of distancing measures for epidemic control planning.
Peer reviewed Open accessCOVID-19PertussisVaccination
Why it matters nowThe authors conclude that both analyses indicate a negative pandemic impact on childhood vaccination uptake, possibly reflecting lingering pandemic effects and/or new post-pandemic factors, and highlight the need for further research into drivers of uptake changes.
Why it matters nowThe findings provide evidence supporting the continuation of BNT162b2 vaccination programs in children under 5 years, a group for which effectiveness data remain limited and vaccination policies have been debated globally.
Why it matters nowThe abstract frames the work as relevant to respiratory virus surveillance and genomic characterisation in primary care. The reported ability to detect and characterise multiple respiratory viruses suggests potential utility for public health surveillance evaluation.
Why it matters nowThe review presents machine learning as a potential way to extract decision-relevant information from wastewater measurements, while identifying data-quality, methodological, implementation, governance, and public-acceptability barriers to broader use.
